"Bioneer, established in 1992, took its first steps as the pioneering ""No. 1 Bio Venture"" company in Korea by supplying reagents used in PCR, including DNA oligonucleotide chemical synthesis services and heat-resistant DNA polymerase. For the past 30 years, Bioneer has consistently made significant contributions to the fields of life sciences, molecular diagnostics, and new drug research and development. It has developed over 300 types of genetic engineering enzymes, proteins, reagents, and advanced equipment essential for establishing an advanced R&D and diagnostic environment similar to that of advanced countries. Bioneer achieved several pioneering milestones. It was the first to develop an automated synthesizer capable of simultaneously synthesizing 384 types of oligos. Utilizing this technology, various DNA and RNA oligos, including the human genome siRNA library, were successfully commercialized. Bioneer also made groundbreaking advancements with the introduction of the world's first stable PCR premix at room temperature, the AccuPower® PCR kit. Furthermore, the invention of ExiProgen™, an automated equipment for protein synthesis, marked another world-first achievement. Guided by the Bio-Pioneer spirit, Bioneer pursues Innovation and Discovery. Through the spirit of Bio-engineer, we consistently endeavor to enhance customer value. By integrating accumulated human knowledge, we will develop innovative products for disease prevention, diagnosis, and treatment, offering utmost value to customers and contributing to human health and happiness."